|
ZFHX3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.316100E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.136400E-01 |
| Normal-vs-Stage2 |
7.452000E-02 |
| Normal-vs-Stage3 |
7.68270000000015E-05 |
| Normal-vs-Stage4 |
2.84870000033521E-07 |
| Stage1-vs-Stage2 |
1.740800E-01 |
| Stage1-vs-Stage3 |
1.580590E-04 |
| Stage1-vs-Stage4 |
2.78509999507293E-08 |
| Stage2-vs-Stage3 |
3.996800E-01 |
| Stage2-vs-Stage4 |
6.157600E-02 |
| Stage3-vs-Stage4 |
7.400000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.696900E-03 |
| Normal-vs-AfricanAmerican |
7.722900E-03 |
| Normal-vs-Asian |
7.378800E-01 |
| Caucasian-vs-AfricanAmerican |
2.224600E-01 |
| Caucasian-vs-Asian |
3.777000E-01 |
| AfricanAmerican-vs-Asian |
1.318790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.974210E-02 |
| Normal-vs-Female |
2.919000E-03 |
| Male-vs-Female |
4.747000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.329400E-01 |
| Normal-vs-Age(41-60Yrs) |
2.434600E-01 |
| Normal-vs-Age(61-80Yrs) |
1.370230E-04 |
| Normal-vs-Age(81-100Yrs) |
2.373000E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.645200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.532000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.520350E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.552700E-04 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.455500E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.932000E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.396000E-01 |
| Normal-vs-Grade 2 |
3.358000E-01 |
| Normal-vs-Grade 3 |
5.62090000000293E-05 |
| Normal-vs-Grade 4 |
2.06650000000863E-06 |
| Grade 1-vs-Grade 2 |
2.759400E-01 |
| Grade 1-vs-Grade 3 |
2.884500E-03 |
| Grade 1-vs-Grade 4 |
3.624100E-04 |
| Grade 2-vs-Grade 3 |
2.407300E-04 |
| Grade 2-vs-Grade 4 |
3.11230000005214E-06 |
| Grade 3-vs-Grade 4 |
6.893700E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.700400E-02 |
| Normal-vs-ccB subtype |
7.294400E-02 |
| ccA subtype-vs-ccB subtype |
6.758400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.142800E-03 |
| Normal-vs-N1 |
2.142300E-02 |
| N0-vs-N1 |
3.500800E-01 |
|
|
